Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

THE TRUTH ABOUT: Is revvity stock underperforming the nasdaq - Caught on Camera

Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a leading provider of health science solutions, offering advanced technologies, expertise, and services that encompass complete workflows from discovery and development to diagnosis and cure. Valued at $12.9 billion by market cap, Revvity serves customers across healthcare, academia and governments, and employs over 11,000 people.

Companies worth $10 billion or more are generally described as "large-cap stocks," Revvity fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the diagnostics & research industry. Revvity revolutionizes what’s possible in healthcare and specializes in translational multi-omics technologies, prediction, screening, detection, diagnosis, and more.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.